Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-10 · accession 0001209191-21-069625 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-14 | 2021-12-10 | NBIX | Lippoldt Darin | CLO | G - Gift | $0.00 | -120 | 34.4K | -0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-10 | G | D | 120 | $0.00 | 34,448 | D | — | — | (F1) Includes an aggregate of 207 shares purchased on February 26, 2021 and August 31, 2021 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. |